article thumbnail

A Deep Dive into What Has Really Changed in Venture Capital

Both Sides of the Table

I’ve heard a lot of people question whether there is too much money in venture capital chasing too few great deals. Others believe that new business models are emerging that could replace venture capital all together. We’re in a new tech bubble!” some have pronounced.

article thumbnail

Illumina Ventures Raises $230M Venture Capital Fund

socalTECH

Illumina Ventures , the early-stage venture capital investor which was founded by San Diego-based life sciences equipment maker Illumina , says it has raised $230M for its first fund.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding Changes in the Software & Venture Capital Industries

Both Sides of the Table

In this three-part series I will explore the ways that the Venture Capital industry has changed over the past 5 years that I would argue are a direct result of changes in the software industry, not the other way around. I will argue that LPs who invest in VC funds will also need to adjust a bit as well. These are very different.

article thumbnail

Do VC Platforms Make Sense?

Both Sides of the Table

In the VC insider baseball world a discussion has gone on about “VC platforms” over the past 5 or so years. While firms define platforms differently, let’s just say they are the services that a VC offers outside of investment capital and partner time on boards or providing intros.

article thumbnail

Untapped Ventures Launches Early Stage VC Fund

socalTECH

Los Angeles-based Untapped Ventures said on Wednesday that it has launched a new, early-stage venture capital fund, which it says invests in companies that "help people live the best version of themselves, personally and professionally." The venture capital fund is led by Founding General Partner George Bandarian.

article thumbnail

Ligand Inks Licensing Deal With Venture Capital Investor

socalTECH

San Diego-based Ligand Pharmaceuticals said on Friday that it has entered into a deal with venture capital investor venBio Partners , which will allow venBio's portfolio companies to enter into a pre-agreed worldwide OmniAb platform license agreement.

article thumbnail

This Week in Venture Capital – Episode 2

Both Sides of the Table

I was on This Week in Venture Capital (TWiVC) again this week with Jason Calacanis. mm in Series A; IdealLab ( Bill Gross ), Index Ventures ( Danny Rimer ), Revolution LLC ( Steve Case ), First Round Capital , BetaWorks , Jason Calcanis. I talked about the platform moves of Twitter and why it should be expected.